L-tyrosine chelated
Selected indexed studies
- Trial of Deferiprone in Parkinson's Disease. (N Engl J Med, 2022) [PMID:36449420]
- Melanin. (Int J Biochem Cell Biol, 1997) [PMID:9451820]
- Parkinson's disease and iron. (J Neural Transm (Vienna), 2020) [PMID:32025811]
_Worker-drafted node — pending editorial review._
Connections
L-tyrosine chelated protects against
L-tyrosine chelated helps
Sources
- Tyrosine hydroxylase inhibitors. (1971) pubmed
- Trial of Deferiprone in Parkinson's Disease. (2022) pubmed
- Site-Specific Immuno-PET Tracer to Image PD-L1. (2019) pubmed
- Melanin. (1997) pubmed
- Parkinson's disease and iron. (2020) pubmed
- [(52)Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer. (2024) pubmed
- Perspectives on metals-based radioimmunotherapy (RIT): moving forward. (2021) pubmed
- Apoferritin-conjugated melanin nanoparticles rescue photoreceptor degeneration via dual iron chelation and ROS scavenging in dry AMD therapy. (2026) pubmed
- The redox chemistry of the Alzheimer's disease amyloid beta peptide. (2007) pubmed
- Measurement of Wee kinase activity. (2005) pubmed